Food News and Research

RSS

Metanx promotes restoration of lost cutaneous sensation in Diabetic Neuropathy patients

PamLab L.L.C., developer and marketer of Metanx®, announced today that the results of a study to determine if nutritional management with Metanx® improves numbness in the feet of patients with Diabetic Neuropathy (DN) was published in the fourth quarter 2010 issue of Reviews in Neurological Diseases. The study demonstrated that Metanx®, a medical food available by prescription, promotes restoration of lost cutaneous sensation in DN patients.

27 Jan 2011

Lancet series examines health issues facing populations in Southeast Asia

"Southeast Asia's 600 million people are facing a raft of new health challenges as the disaster-prone region undergoes some of the world's fastest social change," according to a series of papers and commentary pieces, published Tuesday in the Lancet, Agence France-Presse reports (O'Brien, 1/25).

27 Jan 2011

FDA, Simulations Plus sign RCA to develop QSAR toxicity models

Simulations Plus, a leading provider of software for pharmaceutical discovery and development, announced that the U.S. Food and Drug Administration and Simulations Plus have signed a five-year research collaboration agreement to work together to develop Quantitative Structure-Activity Relationship toxicity models for FDA regulatory and research applications.

27 Jan 2011

FDA Advisory Committee recommends expanded indication for Abbott's RX ACCULINK Carotid Stent System

Abbott today announced that the U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee voted that, for symptomatic and asymptomatic carotid artery disease patients at standard surgical risk, there is reasonable assurance that the benefits of the RX ACCULINK® Carotid Stent System outweigh its risks (Yes: 7, No: 3, Abstain: 1).

27 Jan 2011

FDA issues Complete Response letter for Avodart sNDA for reduction of prostate cancer risk

GlaxoSmithKline (GSK) today announced that the Company has received a Complete Response letter from the U.S. Food and Drug Administration (FDA) for the supplemental New Drug Application (sNDA) for Avodart® (dutasteride) for reducing the risk of prostate cancer in men at increased risk for the disease, defined as those who have had a prior negative biopsy due to clinical concern and have an elevated serum prostate-specific antigen (PSA).

27 Jan 2011

Boston Scientific initiates enrollment in comparative Chinese study of PROMUS Element Everolimus-Eluting Stent

Boston Scientific Corporation today announced the beginning of patient enrollment in the PLATINUM China clinical trial, which is designed to evaluate the safety and effectiveness of the Company's PROMUS Element™ Everolimus-Eluting Platinum Chromium Coronary Stent compared to the TAXUS® Liberte® Paclitaxel-Eluting Coronary Stent in the treatment of patients with a single de novo atherosclerotic lesion.

27 Jan 2011

U.S. FDA announces link between breast implants and ALCL

The U.S. Food and Drug Administration today announced a possible association between saline and silicone gel-filled breast implants and anaplastic large cell lymphoma, a very rare type of cancer.

27 Jan 2011

ASPS, FDA collaborate to establish national breast implant registry

The American Society of Plastic Surgeons (ASPS) is establishing a national registry for breast implants in collaboration with the Food and Drug Administration (FDA). The registry is being developed in response to reports of a rare lymphoma--Anaplastic Large Cell Lymphoma (ALCL)—in a very small number of women with breast implants.

27 Jan 2011

Researchers find food-borne bacteria can cause difficult-to-treat heart infections

Researchers at the University of Illinois at Chicago College of Medicine have found that particular strains of a food-borne bacteria are able to invade the heart, leading to serious and difficult-to-treat heart infections.

27 Jan 2011

Highly-caffeinated energy drinks with no alcohol may pose threat to individuals

Highly-caffeinated energy drinks - even those containing no alcohol - may pose a significant threat to individuals and public health, say researchers at the University of Maryland School of Public Health and Wake Forest University School of Medicine.

27 Jan 2011

Viewpoints: Trying to regulate insurance premium rates, fighting Medicare fraud

Big, powerful industries facing tougher government oversight — the health insurance industry, say — know that the legislative battle in Congress or state capitals is just the first skirmish. The more important fight is over the regulations that implement legislative policies (Michael Hiltzik, 1/25).

26 Jan 2011

ICV Partners acquires Stauber Performance Ingredients

ICV Partners, a private investment firm focused on investments in smaller middle market companies, announced today the acquisition of Stauber Performance Ingredients, Inc., a value-added distributor of nutraceutical ingredients to the dietary supplement industry, from J. H. Whitney & Co.

26 Jan 2011

Microvisk secures £6 million to launch world's first diagnostic SmartStrip

Microvisk Technologies, the developer of a handheld system to monitor the blood clotting status of patients taking the drug Warfarin, has raised £6 million through a rights issue to existing investors in an oversubscribed round. This is the third successful funding round for Microvisk, which has secured £10.5m in the past 12 months - the largest amount raised by a UK life science company**.

26 Jan 2011

Traffic noise and stroke risk: Study

A new study shows that traffic noise may increase the risk of stroke, particularly for older individuals. The study looked at the association between road traffic noise and stroke in more than 51,000 Danish people and found that for every 10-decibel increase in noise level, the risk of stroke increased by 14 percent. In those over 65, the risk of stroke increased 27 percent.

26 Jan 2011

Measles warnings for Australia and New Zealand

In a flight from Brisbane that arrived in Auckland two weeks ago, a child was confirmed to have measles and has been taken to hospital. Five other cases of the virus have been confirmed. At present a further 100 cases are being investigated by the Auckland Regional Public Health Service.

26 Jan 2011

Nordion and Sterigenics sign five year contract for Cobalt-60 supply

Nordion Inc., a leading provider of products and services to the global health science market, today announced it has signed a five-year contract with Sterigenics International, a global leader in contract sterilization and ionization services, for the supply of Cobalt-60. Under the terms of the agreement, this contract extends until October 31, 2015.

25 Jan 2011

Johnson & Johnson fourth quarter sales decreases 5.5% to $15.6 billion

Johnson & Johnson today announced sales of $15.6 billion for the fourth quarter of 2010, a decrease of 5.5% as compared to the fourth quarter of 2009. Operational sales declined 5.1% and the negative impact of currency was 0.4%. Domestic sales declined 8.1%, while international sales declined 3.1%, reflecting an operational decline of 2.3% and a negative currency impact of 0.8%.

25 Jan 2011

Arizona State University sponsored forum addresses child health crises in America

Richard Carmona, MD, MPH, FACS, 17th Surgeon General of the U.S. (2002-2006), said there is "no choice but to act" today to find solutions to the child obesity epidemic and mental health problems in the nation at a forum attended by more than 200 health leaders at the National Press Club. Dr. Carmona made his remarks at "America's Children at Peril: Solving the Child Obesity and Mental Health Epidemics," a forum sponsored by Arizona State University and its College of Nursing & Health Innovation.

25 Jan 2011

Massive drinks mean massive calories

When you're ordering the new Starbucks "trenta" you're not only getting a massive drink (31 ounces) but massive calories (up to 600) - with the potential to pack on more than 60 extra pounds in one year.

25 Jan 2011

Triad alcohol prep pads with ARIXTRA Starter Kits not to be used

GlaxoSmithKline (GSK) has become aware of a United States market recall of all lots of alcohol prep pads, swabs and swabsticks manufactured by the Triad Group and marketed under various brand names. The Triad Group recall has been initiated due to concerns about potential microbial contamination of the alcohol products with Bacillus cereus that could potentially lead to life-threatening infections.

25 Jan 2011